263 related articles for article (PubMed ID: 22056416)
1. Gene expression profiling in adrenocortical neoplasia.
Assie G; Giordano TJ; Bertherat J
Mol Cell Endocrinol; 2012 Mar; 351(1):111-7. PubMed ID: 22056416
[TBL] [Abstract][Full Text] [Related]
2. Molecular markers and the pathogenesis of adrenocortical cancer.
Soon PS; McDonald KL; Robinson BG; Sidhu SB
Oncologist; 2008 May; 13(5):548-61. PubMed ID: 18515740
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling of childhood adrenocortical tumors.
West AN; Neale GA; Pounds S; Figueredo BC; Rodriguez Galindo C; Pianovski MA; Oliveira Filho AG; Malkin D; Lalli E; Ribeiro R; Zambetti GP
Cancer Res; 2007 Jan; 67(2):600-8. PubMed ID: 17234769
[TBL] [Abstract][Full Text] [Related]
4. Characterization of differential gene expression in adrenocortical tumors harboring beta-catenin (CTNNB1) mutations.
Durand J; Lampron A; Mazzuco TL; Chapman A; Bourdeau I
J Clin Endocrinol Metab; 2011 Jul; 96(7):E1206-11. PubMed ID: 21565795
[TBL] [Abstract][Full Text] [Related]
5. Nestin as a marker in the classification of adrenocortical tumors.
Lachenmayer A; Lichtenauer UD; Cox T; Schott M; Malendowicz LK; Goretzki PE; Cupisti K; Scherbaum WA; Bornstein SR; Willenberg HS
Horm Metab Res; 2009 May; 41(5):397-401. PubMed ID: 19294612
[TBL] [Abstract][Full Text] [Related]
6. Expression profiling of adrenocortical neoplasms suggests a molecular signature of malignancy.
Velázquez-Fernández D; Laurell C; Geli J; Höög A; Odeberg J; Kjellman M; Lundeberg J; Hamberger B; Nilsson P; Bäckdahl M
Surgery; 2005 Dec; 138(6):1087-94. PubMed ID: 16360395
[TBL] [Abstract][Full Text] [Related]
7. Loss of growth hormone secretagogue receptor 1a and overexpression of type 1b receptor transcripts in human adrenocortical tumors.
Barzon L; Pacenti M; Masi G; Stefani AL; Fincati K; Palù G
Oncology; 2005; 68(4-6):414-21. PubMed ID: 16020971
[TBL] [Abstract][Full Text] [Related]
8. Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis.
Tömböl Z; Szabó PM; Molnár V; Wiener Z; Tölgyesi G; Horányi J; Riesz P; Reismann P; Patócs A; Likó I; Gaillard RC; Falus A; Rácz K; Igaz P
Endocr Relat Cancer; 2009 Sep; 16(3):895-906. PubMed ID: 19546168
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of microRNAs in adrenocortical tumors.
Singh P; Soon PS; Feige JJ; Chabre O; Zhao JT; Cherradi N; Lalli E; Sidhu SB
Mol Cell Endocrinol; 2012 Mar; 351(1):118-28. PubMed ID: 21996374
[TBL] [Abstract][Full Text] [Related]
10. Myxoid adrenocortical neoplasms: a study of the clinicopathologic features and EGFR gene status of ten Chinese cases.
Zhang J; Sun J; Liang Z; Gao J; Zeng X; Liu T
Am J Clin Pathol; 2011 Nov; 136(5):783-92. PubMed ID: 22031318
[TBL] [Abstract][Full Text] [Related]
11. Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas.
Soon PS; Gill AJ; Benn DE; Clarkson A; Robinson BG; McDonald KL; Sidhu SB
Endocr Relat Cancer; 2009 Jun; 16(2):573-83. PubMed ID: 19218281
[TBL] [Abstract][Full Text] [Related]
12. The molecular basis of adrenocortical cancer.
Lehmann T; Wrzesinski T
Cancer Genet; 2012 Apr; 205(4):131-7. PubMed ID: 22559973
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathology of adrenal cortical tumors: separating adenomas from carcinomas.
Giordano TJ
Endocr Pathol; 2006; 17(4):355-63. PubMed ID: 17525484
[TBL] [Abstract][Full Text] [Related]
14. Transcription factors GATA-6, SF-1, and cell proliferation in human adrenocortical tumors.
Kiiveri S; Liu J; Arola J; Heikkilä P; Kuulasmaa T; Lehtonen E; Voutilainen R; Heikinheimo M
Mol Cell Endocrinol; 2005 Apr; 233(1-2):47-56. PubMed ID: 15767045
[TBL] [Abstract][Full Text] [Related]
15. Integrated genome-wide analysis of genomic changes and gene regulation in human adrenocortical tissue samples.
Gara SK; Wang Y; Patel D; Liu-Chittenden Y; Jain M; Boufraqech M; Zhang L; Meltzer PS; Kebebew E
Nucleic Acids Res; 2015 Oct; 43(19):9327-39. PubMed ID: 26446994
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical evaluation of metallothionein, Mcm-2 and Ki-67 antigen expression in tumors of the adrenal cortex.
Szajerka A; Dziegiel P; Szajerka T; Zabel M; Winowski J; Grzebieniak Z
Anticancer Res; 2008; 28(5B):2959-65. PubMed ID: 19031940
[TBL] [Abstract][Full Text] [Related]
17. Expression of p53 in adrenocortical tumours: clinicopathological correlations.
McNicol AM; Nolan CE; Struthers AJ; Farquharson MA; Hermans J; Haak HR
J Pathol; 1997 Feb; 181(2):146-52. PubMed ID: 9120717
[TBL] [Abstract][Full Text] [Related]
18. DNA and kinetic heterogeneity during the clonal evolution of adrenocortical proliferative lesions.
Blanes A; Diaz-Cano SJ
Hum Pathol; 2006 Oct; 37(10):1295-303. PubMed ID: 16949934
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive DNA methylation analysis of benign and malignant adrenocortical tumors.
Fonseca AL; Kugelberg J; Starker LF; Scholl U; Choi M; Hellman P; Åkerström G; Westin G; Lifton RP; Björklund P; Carling T
Genes Chromosomes Cancer; 2012 Oct; 51(10):949-60. PubMed ID: 22733721
[TBL] [Abstract][Full Text] [Related]
20. ENDOCRINE TUMOURS: The genomics of adrenocortical tumors.
Faillot S; Assie G
Eur J Endocrinol; 2016 Jun; 174(6):R249-65. PubMed ID: 26739091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
